{
    "organizations": [],
    "uuid": "12f8f5806a225c6953137cdb01998ab51831451b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-celon-pharma-signs-deal-for-indust/brief-celon-pharma-signs-deal-for-industrial-development-and-production-for-clinical-trial-of-anti-vegf-protein-idUSFWN1PP0EM",
    "ord_in_thread": 0,
    "title": "BRIEF-Celon Pharma Signs Deal For Industrial Development And Production For Clinical Trial Of Anti-VEGF Protein",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 30 (Reuters) - Celon Pharma SA:\n* SIGNS CONTRACT WITH BIOTECHPHARMA FOR INDUSTRIAL DEVELOPMENT AND PRODUCTION FOR CLINICAL TRIAL IN GMP QUALITY OF ANTI-VEGF PROTEIN\n* VALUE OF CONTRACT WITH BIOTECHPHARMA IS ABOUT 2-3 MILLION EUROS Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-30T15:38:00.000+02:00",
    "crawled": "2018-01-31T16:25:56.054+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "celon",
        "pharma",
        "sa",
        "sign",
        "contract",
        "biotechpharma",
        "industrial",
        "development",
        "production",
        "clinical",
        "trial",
        "gmp",
        "quality",
        "protein",
        "value",
        "contract",
        "biotechpharma",
        "million",
        "euro",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}